Improving Hepatitis C Treatment in Injection Drug Users

Completed · Phase 4

Conditions studied: Hepatitis C, Liver Diseases, Drug Abuse, Alcoholism

In brief

The overall goal of the research project is to improve the outcome of medical care for injection drug users (IDUs) with Hepatitis C viral (HCV) infection. Hypothesis: An intervention designed to improve the rate of HCV treatment completion and sustained virologic response (SVR) in IDUs will increase access by integrating HCV medical care into a substance abuse treatment program.

Key facts

Study ID

NCT00148031

Run by

State University of New York - Upstate Medical University

People needed

111

Starts

2003-09-01

Expected to finish

2007-03-01

Last updated by the study team

2013-04-24

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-65 years of age.
• Enrolled in outpatient methadone maintenance treatment for greater than 3 months.
• Hepatitis C RNA positive.
• Willingness to accept HCV treatment.
• Subject has non-VA (Veteran's Administration) medical insurance or is willing to bear any and all expenses associated with Hepatitis C medical treatment.

You may not qualify if…

• In need of inpatient drug or alcohol detoxification.
• Currently receiving the standard Hepatitis C treatment
• Unable to give adequate informed consent.
• Pregnant, nursing, or planning to become pregnant during HCV treatment or within 6 months following completion of treatment.
• Male subject who has a female sexual partner who is pregnant or planning to become pregnant at any time during HCV treatment or within 6 months following completion of treatment.
• Female subject or male subject who has a female sexual partner who is of child bearing years and not using two medically approved forms of contraception.
• Subject has made a commitment to attend residential care psychiatric or drug/alcohol rehabilitation, which would lead to unavailability to attend regularly scheduled medical care and research visits.
• Subject did not attend all required screening appointments.
• Subject has a legal proceeding whose outcome may lead to incarceration within 3 months of intake.

Where it is running

• Crouse Chemical Dependency Treatment Services — Syracuse, New York, United States
• SUNY Upstate Medical University - Department of Gastroenterology — Syracuse, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.